12/01/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
11/29/2024
3:15 PM | Coya Therapeutics (Filer)
| Form 424B3 | |
11/20/2024
4:15 PM | Coya Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
5:08 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
2:37 PM | Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/06/2024
7:06 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:02 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/05/2024
4:02 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:27 PM | Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:42 AM | Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
3:42 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:00 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
8:08 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
8:10 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:04 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:13 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
5:10 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
4:31 PM | Coya Therapeutics (Filer)
| Form 424B3 | |
06/23/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
7:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 PM | Berman Howard (Reporting)
Coya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:20 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
4:21 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:40 PM | Coya Therapeutics (Filer)
| Form ARS | |
03/28/2024
3:30 PM | Coya Therapeutics (Filer)
| Form DEF 14A | |
03/28/2024
3:35 PM | Coya Therapeutics (Filer)
| Form DEFA14A | |
03/19/2024
7:21 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:27 AM | Coya Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:00 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:46 PM | Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
| Form SC 13G/A | |
02/07/2024
5:55 PM | Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
7:00 PM | Berman Howard (Reporting)
Coya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
AI breakthrough about to upend industry (Ad) Everyone is talking about AI right now.
The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI.
But here’s the thing. I urge you to watch it now. |
01/19/2024
7:15 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
01/04/2024
3:46 PM | Coya Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:05 PM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
7:00 AM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Free COYA Stock Alerts